A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants

Brigitte M. T. Hougardy, Nathalie Reesink-Peters, Fiona A. J. van den Heuvel, Klaske A. ten Hoor, Harry Hollema, Elisabeth G. E. de Vries, Steven de Jong, Ate G. J. van der Zee*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Abstract

Development of medical therapies for high-grade cervical intraepithelial neoplasia (CIN II/III) is hampered by the lack of CIN II/III cell lines. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis upon binding to its receptors DR4 or DR5. Proteasome inhibition by MG132 sensitized cervical cancer cell lines to recombinant human (rh)TRAIL. In our study, we aimed to develop an ex vivo model for CIN II/III and to investigate (lie apoptosis-inducing effect of rhTRAIL, and/or MG132 in cervical explants front CIN II/III patients. A short-term ex viva culture system was optimized for cervical biopsies, in which explants from normal cervix and CIN II/III lesions were exposed to either rhTRAIL, (1 mu g/ml), MG132 (5 mu M) or the combination and compared to untreated explants for apoptosis induction. Normal cervix (n = 90) and CIN II/III (n = 24) explants could be reproducibly put in culture and kept viable for of) to 7 days using a transwell membrane system. CIN II/III explants (n = 5) were highly sensitive to rhTRAIL plus MG132 (mean % apoptosis: 91 +/- 5) compared to normal cervix (n = 10) treated with rhTRAIL, plus MG132 (mean % apoptosis: 24 +/- 10, p <0.0001), while monotherapy with either rhTRAIL, MG132 or medium resulted in a mean % apoptosis

Original languageEnglish
Pages (from-to)1457-1465
Number of pages9
JournalInternational Journal of Cancer
Volume123
Issue number6
DOIs
Publication statusPublished - 15-Sep-2008

Keywords

  • cervical explants
  • rhTRAIL
  • apoptosis
  • proteasome inhibitor
  • HUMAN-PAPILLOMAVIRUS
  • INTRAEPITHELIAL NEOPLASIA
  • HUMAN KERATINOCYTES
  • CELL-PROLIFERATION
  • DEATH RECEPTORS
  • EXPRESSION
  • LIGAND
  • CANCER
  • CARCINOGENESIS
  • BORTEZOMIB

Cite this